Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 8 studies | 53% ± 26% | |
hepatocyte | 6 studies | 67% ± 21% | |
endothelial cell | 4 studies | 20% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 25602.90 | 226 / 226 | 82% | 58.03 | 332 / 406 |
kidney | 100% | 15187.34 | 89 / 89 | 82% | 74.12 | 735 / 901 |
thymus | 94% | 22.48 | 612 / 653 | 0% | 0 | 0 / 605 |
pancreas | 92% | 9.97 | 301 / 328 | 0% | 0 | 0 / 178 |
adipose | 83% | 17.80 | 1001 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 82% | 8.53 | 212 / 258 | 0% | 0 | 0 / 230 |
breast | 80% | 17.18 | 368 / 459 | 0% | 0.01 | 1 / 1118 |
esophagus | 73% | 8.32 | 1058 / 1445 | 1% | 0.07 | 1 / 183 |
uterus | 71% | 9.01 | 120 / 170 | 0% | 0.02 | 1 / 459 |
intestine | 68% | 6.75 | 655 / 966 | 0% | 0.08 | 1 / 527 |
bladder | 67% | 6.24 | 14 / 21 | 0% | 0 | 0 / 504 |
stomach | 60% | 4.64 | 214 / 359 | 0% | 0 | 0 / 286 |
muscle | 58% | 4.76 | 469 / 803 | 0% | 0 | 0 / 0 |
prostate | 58% | 6.91 | 141 / 245 | 0% | 0 | 0 / 502 |
lung | 55% | 4.61 | 319 / 578 | 0% | 0 | 0 / 1155 |
ovary | 51% | 4.06 | 92 / 180 | 0% | 0 | 0 / 430 |
spleen | 44% | 32.22 | 106 / 241 | 0% | 0 | 0 / 0 |
skin | 40% | 3.53 | 727 / 1809 | 0% | 0 | 0 / 472 |
blood vessel | 38% | 3.44 | 502 / 1335 | 0% | 0 | 0 / 0 |
heart | 30% | 2.14 | 260 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 30% | 8.45 | 280 / 929 | 0% | 0 | 0 / 0 |
brain | 15% | 0.84 | 389 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070328 | Biological process | triglyceride homeostasis |
GO_0006633 | Biological process | fatty acid biosynthetic process |
GO_0006637 | Biological process | acyl-CoA metabolic process |
GO_0036112 | Biological process | medium-chain fatty-acyl-CoA metabolic process |
GO_0042593 | Biological process | glucose homeostasis |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0015645 | Molecular function | fatty acid ligase activity |
GO_0004321 | Molecular function | fatty-acyl-CoA synthase activity |
GO_0031956 | Molecular function | medium-chain fatty acid-CoA ligase activity |
GO_0102391 | Molecular function | decanoate-CoA ligase activity |
GO_0018858 | Molecular function | benzoate-CoA ligase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | ACSM2A |
Protein name | Acyl-CoA synthetase medium chain family member 2A Acyl-coenzyme A synthetase ACSM2A, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 2A) (Benzoate--CoA ligase) (EC 6.2.1.25) (Butyrate--CoA ligase 2A) (Butyryl-coenzyme A synthetase 2A) (Middle-chain acyl-CoA synthetase 2A) medium-chain acyl-CoA ligase (EC 6.2.1.2) |
Synonyms | ACSM2 MACS2 |
Description | FUNCTION: Catalyzes the activation of fatty acids by CoA to produce an acyl-CoA, the first step in fatty acid metabolism (By similarity). Capable of activating medium-chain fatty acids (e.g. butyric (C4) to decanoic (C10) acids), and certain carboxylate-containing xenobiotics, e.g. benzoate (By similarity). . |
Accessions | ENST00000219054.10 ENST00000576361.5 ENST00000574692.5 ENST00000574251.5 ENST00000575690.5 E7EPS5 ENST00000571894.1 I3L2Y5 ENST00000417235.6 ENST00000573854.6 ENST00000396104.2 F5GWL3 I3L339 I3L438 Q08AH3 |